Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone in Iron-Overloaded Low Risk MDS
NCT02477631Phase 2Completed
- Sponsor
- Sheba Medical Center
- Start
- Feb 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferiprone in iron overload, sponsored by Sheba Medical Center. Started Feb 2016; status: completed.
02
Drugs
deferiprone
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT02477631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477631.